SI2651888T1 - Derivati n-((1h-indol-3-il)-4-benzil)benzamida in n-((1h-pirolo(2,3-b) piridin-3-il)-alkil)-4-benzil)benzamida kot inhibitor agregacije alfa sinukleina, za zdravljenje nevrodegenerativnih motenj - Google Patents
Derivati n-((1h-indol-3-il)-4-benzil)benzamida in n-((1h-pirolo(2,3-b) piridin-3-il)-alkil)-4-benzil)benzamida kot inhibitor agregacije alfa sinukleina, za zdravljenje nevrodegenerativnih motenjInfo
- Publication number
- SI2651888T1 SI2651888T1 SI201131263T SI201131263T SI2651888T1 SI 2651888 T1 SI2651888 T1 SI 2651888T1 SI 201131263 T SI201131263 T SI 201131263T SI 201131263 T SI201131263 T SI 201131263T SI 2651888 T1 SI2651888 T1 SI 2651888T1
- Authority
- SI
- Slovenia
- Prior art keywords
- benzyl
- alkyl
- benzamide
- pyrrolo
- indol
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
- C07D209/14—Radicals substituted by nitrogen atoms, not forming part of a nitro radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1021103.5A GB201021103D0 (en) | 2010-12-13 | 2010-12-13 | New compounds for the treatment of neurodegenerative diseases |
| EP11805450.1A EP2651888B1 (en) | 2010-12-13 | 2011-12-13 | N-((1H-indol-3-yl)-alkyl)-4-benzyl)benzamide and N-((1H-pyrrolo[2,3-b]pyridin-3-yl)-alkyl)-4-benzyl)benzamide derivatives as alpha synuclein aggregation inhibitors for the treatment of neurodegenerative disorders |
| PCT/EP2011/072568 WO2012080221A1 (en) | 2010-12-13 | 2011-12-13 | New compounds for the treatment of neurodegenerative diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2651888T1 true SI2651888T1 (sl) | 2017-10-30 |
Family
ID=43567100
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI201131263T SI2651888T1 (sl) | 2010-12-13 | 2011-12-13 | Derivati n-((1h-indol-3-il)-4-benzil)benzamida in n-((1h-pirolo(2,3-b) piridin-3-il)-alkil)-4-benzil)benzamida kot inhibitor agregacije alfa sinukleina, za zdravljenje nevrodegenerativnih motenj |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9266832B2 (sl) |
| EP (1) | EP2651888B1 (sl) |
| JP (1) | JP6050241B2 (sl) |
| CN (1) | CN103261156B (sl) |
| CA (1) | CA2819171C (sl) |
| DK (1) | DK2651888T3 (sl) |
| ES (1) | ES2637288T3 (sl) |
| GB (1) | GB201021103D0 (sl) |
| HR (1) | HRP20171186T1 (sl) |
| HU (1) | HUE033277T2 (sl) |
| SI (1) | SI2651888T1 (sl) |
| WO (1) | WO2012080221A1 (sl) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201021104D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| GB201021103D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | New compounds for the treatment of neurodegenerative diseases |
| KR20160106627A (ko) * | 2013-12-30 | 2016-09-12 | 라이프에스씨아이 파마슈티컬스, 인크. | 치료적 억제 화합물 |
| BR112016017344B1 (pt) | 2014-01-29 | 2023-05-16 | Ucb Biopharma Sprl | Composto de heteroaril amida, sua composição farmacêutica, seu uso, e método de interferir ou de prevenir, retardar, inverter, ou inibir a agregação da proteína ou peptídeo numa célula |
| CN104744353B (zh) * | 2015-03-31 | 2017-11-24 | 山东友帮生化科技有限公司 | 2‑氨基‑3‑碘‑5‑氯吡啶的合成方法 |
| CN105130978B (zh) * | 2015-07-22 | 2017-11-21 | 中国人民解放军军事医学科学院基础医学研究所 | 一种化合物及其在帕金森疾病方面的应用 |
| US10975066B2 (en) | 2015-07-29 | 2021-04-13 | UCB Biopharma SRL | Bis-heteroaryl derivatives as modulators of protein aggregation |
| MA46589A (fr) | 2016-10-24 | 2019-08-28 | Yumanity Therapeutics Inc | Composés et utilisations de ces derniers |
| BR112019011931A2 (pt) | 2017-01-26 | 2019-10-29 | Ucb Biopharma Sprl | derivados de alcóxi bis-heteroarila como moduladores da agregação de proteína |
| MA47370A (fr) | 2017-01-26 | 2021-03-24 | UCB Biopharma SRL | Dérivés bis-hétéroaryliques en tant que modulateurs de l'agrégation des protéines |
| CA3045221A1 (en) | 2017-01-26 | 2018-08-02 | Ucb Biopharma Sprl | Bicyclic bis-heteroaryl derivatives as modulators of protein aggregation |
| WO2018158160A1 (en) | 2017-02-28 | 2018-09-07 | Universitat Autonoma De Barcelona | (nitro-phenyl)-nitropyridine compounds for treating synucleinopathies |
| WO2019025424A1 (en) | 2017-08-04 | 2019-02-07 | Universitat Autonoma De Barcelona | COMPOUNDS FOR TREATING SYNUCLEINOPATHIES |
| CA3083000A1 (en) | 2017-10-24 | 2019-05-02 | Yumanity Therapeutics, Inc. | Compounds and uses thereof |
| WO2019161917A1 (en) | 2018-02-23 | 2019-08-29 | Universitat Autonoma De Barcelona | 4-substituted 1-ethenylsulfonyl-2-nitrobenzene compounds for treating synucleinopathies |
| FI3860998T3 (fi) | 2018-10-05 | 2024-03-27 | Annapurna Bio Inc | Yhdisteitä ja koostumuksia apj-reseptorin aktiivisuuteen liittyvien tautitilojen hoitoon |
| CN114174273A (zh) * | 2019-03-22 | 2022-03-11 | 优曼尼蒂治疗公司 | 化合物和其用途 |
| WO2021025723A1 (en) * | 2019-08-02 | 2021-02-11 | Acelot, Inc. | Small molecule drugs and related methods for treatment of diseases related to tdp-43, alpha-synuclein, huntingtin's protein and tau protein oligomer formation |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3345376A (en) * | 1963-11-06 | 1967-10-03 | Upjohn Co | Polyhydro-6-methoxy-1-(3, 4, 5-trimethoxyphenyl)-9h-pyrido[3, 4-b]indoles |
| IL130169A (en) * | 1999-05-27 | 2006-08-20 | Neurim Pharma 1991 | Indole derivatives, and pharmaceutical preparations, skin protection preparations, and cosmetics containing them |
| US6306890B1 (en) * | 1999-08-30 | 2001-10-23 | Vanderbilt University | Esters derived from indolealkanols and novel amides derived from indolealkylamides that are selective COX-2 inhibitors |
| GB9922171D0 (en) * | 1999-09-21 | 1999-11-17 | Zeneca Ltd | Chemical compounds |
| CA2411165A1 (en) * | 2000-05-02 | 2002-12-11 | Meiji Seika Kaisha, Ltd. | Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof |
| DOP2002000332A (es) * | 2001-02-14 | 2002-08-30 | Warner Lambert Co | Inhibidores de piridina de metaloproteinasas de la matriz |
| OA13151A (en) | 2003-02-26 | 2006-12-13 | Sugen Inc | Aminoheteroaryl compounds as protein kinase inhibitors. |
| US7795295B2 (en) | 2004-07-01 | 2010-09-14 | The Regents Of The University Of California | Small molecule inhibition of PDZ-domain interaction |
| CA2588389A1 (en) * | 2004-11-23 | 2006-06-22 | Ptc Therapeutics, Inc. | Substituted phenols as active agents inhibiting vegf production |
| JP2009501709A (ja) | 2005-07-12 | 2009-01-22 | バイエル・クロツプサイエンス・エス・アー | 新規ベンゾヘテロシクリルエチルベンズアミド誘導体 |
| EP2149552A1 (de) * | 2008-07-30 | 2010-02-03 | Bayer Schering Pharma AG | 5,6 substituierte Benzamid-Derivate als Modulatoren des EP2-Rezeptors |
| EP2403835A1 (en) * | 2009-03-03 | 2012-01-11 | Pfizer Inc. | Novel phenyl imidazoles and phenyl triazoles as gamma-secretase modulators |
| GB0910003D0 (en) * | 2009-06-11 | 2009-07-22 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
| ES2360435B1 (es) * | 2009-10-30 | 2012-05-04 | Consejo Superior De Investigaciones Cientificas (Csic) (70%) | Derivados de biss (aralquil) amino y sistemas (6+5)-heteroaromaticos y su uso en el tratamiento de patologias neurodegenerativas, incluida la enfermedad de alzheimer |
| JPWO2012042621A1 (ja) | 2010-09-29 | 2014-02-03 | 味の素株式会社 | 塩味増強剤 |
| KR20140009251A (ko) | 2010-11-15 | 2014-01-22 | 애브비 인코포레이티드 | Ｎａｍｐｔ 및 ｒｏｃｋ 억제제 |
| GB201021103D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | New compounds for the treatment of neurodegenerative diseases |
| GB201021104D0 (en) | 2010-12-13 | 2011-01-26 | Univ Leuven Kath | Novel compounds for the treatment of neurodegenerative diseases |
-
2010
- 2010-12-13 GB GBGB1021103.5A patent/GB201021103D0/en not_active Ceased
-
2011
- 2011-12-13 EP EP11805450.1A patent/EP2651888B1/en active Active
- 2011-12-13 DK DK11805450.1T patent/DK2651888T3/en active
- 2011-12-13 CA CA2819171A patent/CA2819171C/en active Active
- 2011-12-13 WO PCT/EP2011/072568 patent/WO2012080221A1/en active Application Filing
- 2011-12-13 US US13/993,723 patent/US9266832B2/en active Active
- 2011-12-13 ES ES11805450.1T patent/ES2637288T3/es active Active
- 2011-12-13 SI SI201131263T patent/SI2651888T1/sl unknown
- 2011-12-13 HU HUE11805450A patent/HUE033277T2/en unknown
- 2011-12-13 JP JP2013542577A patent/JP6050241B2/ja active Active
- 2011-12-13 CN CN201180059955.9A patent/CN103261156B/zh not_active Expired - Fee Related
-
2017
- 2017-08-02 HR HRP20171186TT patent/HRP20171186T1/hr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130274260A1 (en) | 2013-10-17 |
| DK2651888T3 (en) | 2017-08-28 |
| CN103261156B (zh) | 2016-12-28 |
| JP2013544872A (ja) | 2013-12-19 |
| US9266832B2 (en) | 2016-02-23 |
| CN103261156A (zh) | 2013-08-21 |
| EP2651888A1 (en) | 2013-10-23 |
| HRP20171186T1 (hr) | 2017-10-20 |
| EP2651888B1 (en) | 2017-05-17 |
| GB201021103D0 (en) | 2011-01-26 |
| CA2819171C (en) | 2020-02-18 |
| CA2819171A1 (en) | 2012-06-21 |
| WO2012080221A1 (en) | 2012-06-21 |
| HUE033277T2 (en) | 2017-11-28 |
| JP6050241B2 (ja) | 2016-12-21 |
| ES2637288T3 (es) | 2017-10-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI2651888T1 (sl) | Derivati n-((1h-indol-3-il)-4-benzil)benzamida in n-((1h-pirolo(2,3-b) piridin-3-il)-alkil)-4-benzil)benzamida kot inhibitor agregacije alfa sinukleina, za zdravljenje nevrodegenerativnih motenj | |
| ZA201205505B (en) | Substituted n-(1h-indazol-4-yl)imidazo[1,2-a]pyridine-3-carboxamide compounds as cfms inhibitors | |
| IL257581A (en) | New dihydropyrimidineisoquinolinones and their pharmaceutical preparations for the treatment of inflammatory disorders | |
| EP2552433A4 (en) | COMPOSITIONS AND METHODS OF TREATING SOMATOSENSORY DISEASES | |
| EP2734500A4 (en) | SELECTIVE HISTONDEACETYLASE-6 INHIBITORS FOR THE TREATMENT OF BONE DISORDERS | |
| WO2014028591A3 (en) | N-ALKYLATED INDOLE AND INDAZOLE COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF | |
| WO2014120808A8 (en) | Pyridone amides as modulators of sodium channels | |
| EP2726141A4 (en) | DEVICE, SYSTEM AND METHODS FOR ORAL DELIVERY OF THERAPEUTIC COMPOUNDS | |
| ZA201209632B (en) | Imidazopyridine derivatives, process for the preparation thereof and therapeutic use thereof | |
| SI2651939T1 (sl) | SUBSTITUIRANE N-(1H-INDAZOL-4-IL)IMIDAZO(1,2-a)PIRIDIN-3-KARBOKSAMIDNE SPOJINE KOT INHIBITORJI RECEPTORSKE TIROZINSKE KINAZE TIPA III | |
| HK1206615A1 (en) | Mglu2/3 antagonists for the treatment of autistic disorders mglu2/3 | |
| EP2571360A4 (en) | METHODS AND FORMULATIONS FOR THE TREATMENT BY OXYTOCINE OF DISORDERS RELATED TO THE USE OF TOXIC SUBSTANCES, PSYCHIATRIC DISORDERS AND OTHER DISORDERS | |
| SG11201401202YA (en) | Antagonists of il17c for the treatment of inflammatory disorders | |
| ZA201402907B (en) | Disubstituted 3,4-diamino-3-cyclobutene-1,2-dione compounds for use in the treatment of chemokine-mediated pathologies | |
| HK1182015A1 (zh) | 活性藥物化合物用於治療中樞神經系統病症的用途 | |
| IL228893A0 (en) | PSD-95 dimer traces with high affinity as effective neuroprotectants against nizkymochinaiskeim and for the treatment of pain | |
| HK1197235A1 (zh) | 二氫吡唑、其藥物組合物及其治療生育障礙的用途 | |
| ZA201206898B (en) | Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferatiive disorders | |
| EP2681209A4 (en) | COMPOUNDS AND METHODS FOR TREATING PAIN AND OTHER DISEASES | |
| IL227475A0 (en) | Methods and kits for evaluating the pro-coagulation activity of heparanase' Preparations containing heparanase and methods for the treatment of disorders related to coagulation |